Testing effectiveness (Phase 2)Active Not RecruitingNCT07651475What this trial is testingStudy of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)Who this might be right forR/R AML Liping Dou 32
Testing effectiveness (Phase 2)Study completedNCT03068819What this trial is testingCytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell TransplantWho this might be right forAcute Myeloid Leukemia Washington University School of Medicine 62
Early research (Phase 1)Study completedNCT03672695What this trial is testingPhase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia.Who this might be right forAcute Myeloid Leukaemia Institut de Recherches Internationales Servier 37
Not applicableStudy completedNCT06648512What this trial is testingAssociation of Ex Vivo Drug Response ( EVDR) and Clinical Outcome in Acute Myeloid Leukaemia (EXCYTE-2)Who this might be right forAcute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML) Relapse Exscientia AI Limited 91
Large-scale testing (Phase 3)Study completedNCT01147939What this trial is testingStudy of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)Who this might be right forAcute Myeloid Leukemia (AML) Clavis Pharma 381
Testing effectiveness (Phase 2)Ended earlyNCT03176277What this trial is testingONO-7475 in Patients With Acute LeukemiasWho this might be right forAcute LeukemiaMyelodysplastic Syndromes Ono Pharmaceutical Co., Ltd. 42
Not applicableStudy completedNCT00038675What this trial is testingTherapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib MesylateWho this might be right forChronic Myelomonocytic LeukemiaChronic Myeloid LeukemiaPolycythemia Vera+2 more M.D. Anderson Cancer Center 125
Very early researchWithdrawnNCT07338357What this trial is testingClinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AMLWho this might be right forAML (Acute Myeloid Leukemia)CAR-T First Affiliated Hospital of Guangxi Medical University
Testing effectiveness (Phase 2)Study completedNCT00254423What this trial is testingDasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous LeukemiaWho this might be right forChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositivePhiladelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia M.D. Anderson Cancer Center 150
Not applicableEnded earlyNCT04858594What this trial is testingStudy of Periodontitis and Blood Stream Infection in AML Patients Receiving ChemotherapyWho this might be right forAcute Myeloid Leukemia Masonic Cancer Center, University of Minnesota 3
Not applicableStudy completedNCT02891551What this trial is testingAn Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the NetherlandsWho this might be right forMyelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute Celgene 209
Not applicableStudy completedNCT00386373What this trial is testingUse and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia PatientsWho this might be right forLeukemia M.D. Anderson Cancer Center 10
Early research (Phase 1)Ended earlyNCT04250051What this trial is testingIvosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forRecurrent Acute Myeloid LeukemiaRecurrent Myelodysplastic SyndromeRecurrent Myeloproliferative Neoplasm+5 more Northwestern University 2
Early research (Phase 1)Looking for participantsNCT05188170What this trial is testingNiclosamide in Pediatric Patients With Relapsed and Refractory AMLWho this might be right forAcute Myeloid Leukemia (AML) Stanford University 16
Testing effectiveness (Phase 2)UnknownNCT04913922What this trial is testingRelatlimab With Nivolumab and 5-Azacytidine for the Treatment of AMLWho this might be right forAcute Myeloid Leukemia Ludwig-Maximilians - University of Munich 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07761702What this trial is testingUmbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-Risk AMLWho this might be right forAML (Acute Myelogenous Leukemia) Shanghai Jiao Tong University School of Medicine 132
Not applicableEnded earlyNCT01169753What this trial is testingNuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia PatientsWho this might be right forChronic Myeloid Leukemia M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT04230239What this trial is testingClinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid LeukemiaWho this might be right forNewly Diagnosed Secondary or High Risk AML PETHEMA Foundation 59
Testing effectiveness (Phase 2)Ended earlyNCT02712905What this trial is testingAn Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced MalignanciesWho this might be right forSolid Tumors and Hematologic Malignancy Incyte Corporation 116
Testing effectiveness (Phase 2)Looking for participantsNCT05092451What this trial is testingPhase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological MalignancesWho this might be right forB-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more M.D. Anderson Cancer Center 80